The worldwide challenge of the dementias: a role for B vitamins and homocysteine? (Q37246161)

19 August 2017

1 reference

title

The worldwide challenge of the dementias: a role for B vitamins and homocysteine? (English)

1 reference

19 August 2017

0 references

0 references

0 references

A David Smith

1

1 reference

19 August 2017

1 June 2008

1 reference

Food and Nutrition Bulletin

19 August 2017

1 reference

19 August 2017

29

1 reference

19 August 2017

2 Suppl

1 reference

19 August 2017

S143-72

1 reference

The global burden of disease study: implications for neurology

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Worldwide prevalence and incidence of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The effect of different diagnostic criteria on the prevalence of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Methodological issues for population-based research into dementia in developing countries. A position paper from the 10/66 Dementia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dementia diagnosis in developing countries: a cross-cultural validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The magnitude of dementia occurrence in the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Alzheimer Disease in the US Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The end of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Can dementia be prevented? Brain aging in a population-based context

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Human aging: usual and successful

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Preventable senility: a call for action against the vascular dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The epidemiologic study of dementia: a life-long quest?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Preventing chronic diseases: how many lives can we save?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Facts and recommendations about total homocysteine determinations: an expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Alzheimer's disease: a 'cobalaminergic' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total serum homocysteine in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, vitamin B6, and vascular disease in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Relation between plasma homocysteine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

B vitamins, cognition, and aging: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine in neuropsychiatric disorders of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive function in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Diagnosing dementia: interrater reliability assessment and accuracy of the NINCDS/ADRDA criteria versus CERAD histopathological criteria for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma total homocysteine and cognitive performance in a volunteer elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive function in a population-based study of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive performance in the Framingham offspring study: age is important

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine levels and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive decline in healthy elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Association between nutritional status and cognitive functioning in a healthy elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hyperhomocysteinemia and vitamin score: correlations with silent brain ischemic lesions and brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vitamin B(12) and folate in relation to the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Holotranscobalamin--a first choice assay for diagnosing early vitamin B deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Basic methods for sensitivity analysis of biases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The effect of folic acid supplementation on plasma homocysteine in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Imaging the progression of Alzheimer pathology through the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

A life-course approach to the aetiology of late-onset dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Biological and clinical implications of the MTHFR C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The age-dependent relation of blood pressure to cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

CSF-folate levels are decreased in late-onset AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The central nervous system in animal models of hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate deficiency increases postischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Elevated levels of plasma homocysteine are associated with neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Increased homocysteine and decreased adenosine formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Functional vitamin B(12) deficiency and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hyperhomocysteinaemia in Alzheimer's disease and expression of cell cycle markers in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Cell cycle activation linked to neuronal cell death initiated by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The ubiquitin‐like domain of Herp is involved in Herp degradation, but not necessary for its enhancement of amyloid β‐protein generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Early life circumstances and late life Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Evil forces and vulnerable brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Effects of folate and vitamin B12 on cognitive function in adults and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dementia after stroke: the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Improvement in stroke mortality in Canada and the United States, 1990 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Review of the magnitude of folate and vitamin B12 deficiencies worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Causes of vitamin B12 and folate deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vitamin B12 deficiency as a worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The global stroke initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Aggregation of vascular risk factors and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Cholesterol in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Atherosclerosis of cerebral arteries in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Prospective study of alcohol consumption and risk of dementia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Alcohol intake and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

An active and socially integrated lifestyle in late life might protect against dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Change in body mass index and risk of incident Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Low free testosterone is an independent risk factor for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Free testosterone and risk for Alzheimer disease in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Testosterone and Alzheimer disease: is it men's turn now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Depressive symptoms, sex, and risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine in 80-year-olds: relationships to medical, psychological and social variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate status, vascular disease and cognition in elderly Canadians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Identification of cognitive impairment in the elderly: homocysteine is an early marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: a population-based study of healthy very old adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hyperhomocysteinemia in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Serum vitamin B12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and affective functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Effect of low levels of serum vitamin B12 and folic acid on cognitive performance in old age: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The influence of serum vitamin B12 and folate status on cognitive functioning in very old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total homocysteine and cognitive deterioration in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Brain hydrogen sulfide is severely decreased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine and cognitive impairment in an older British African-Caribbean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hormone replacement therapy and cognitive performance: the role of homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Alzheimer's disease and total plasma aminothiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine as a risk factor for cognitive impairment in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folic acid and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vitamin B12, folate, homocysteine and dementia: are they really related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vascular risk factors and cognitive function in a sample of independently living men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Hyperhomocysteinemia is associated with lower performance on memory tasks in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: the paradoxical effect of the superimposed type II diabetes mellitus condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Elevated methylmalonic acid is related to cognitive impairement in older adults enrolled in an elderly nutrition program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and B vitamins in mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Vitamin B-12, serum folate, and cognitive change between 11 and 79 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The transmethylation cycle in the brain of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Folate and the methylenetetrahydrofolate reductase 677C-->T mutation correlate with cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Biochemical values in persons older than 82 years of age: report from a population‐based study of twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and brain atrophy on MRI of non-demented elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Lipoprotein-associated phospholipase A2 is associated with risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Cognitive and Behavioral Correlates of Low Vitamin B12 Levels in Elderly Patients With Progressive Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

Homocysteine and B Vitamins Relate to Brain Volume and White-Matter Changes in Geriatric Patients With Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F15648265080292S119

10.1177/15648265080292S119

21 January 2018

Identifiers

DOI

0 references

PubMed ID

18709889

1 reference

PubMed ID

18709889